Analysis of COVID-19 Treatment Domains and Mortality Outcomes

The chapter presents the results of a study involving nearly 4,900 patients from various regions focusing on COVID-19 treatment outcomes up to day 180. It explores the effects of interventions like interleukin-6 receptor antagonists, antiplatelets, and antivirals on mortality rates and potential harm.